A share price of Biodesix Inc [BDSX] is currently trading at $9.88, up 22.28%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BDSX shares have gain 63.85% over the last week, with a monthly amount glided 23.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biodesix Inc [NASDAQ: BDSX] stock has seen the most recent analyst activity on May 14, 2025, when William Blair downgraded its rating to a Mkt Perform. On July 26, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $3 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $2.80 on May 13, 2024. Lake Street initiated its recommendation with a Buy and recommended $3 as its price target on May 03, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 17, 2021, and downed its price target to $11. In a note dated November 23, 2020, William Blair initiated an Outperform rating.
Biodesix Inc experienced fluctuations in its stock price throughout the past year between $3.44 and $26.00. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Biodesix Inc [NASDAQ: BDSX] shares were valued at $9.88 at the most recent close of the market. An investor can expect a potential return of 102.43% based on the average BDSX price forecast.
Analyzing the BDSX fundamentals
Trailing Twelve Months sales for Biodesix Inc [NASDAQ:BDSX] were 80.17M which represents 19.93% growth. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at -0.41%, Pretax Profit Margin comes in at -0.49%, and Net Profit Margin reading is -0.49%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -5.04 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -42.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Biodesix Inc [NASDAQ:BDSX] is 1.84. Further, the Quick Ratio stands at 1.76, while the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 0.98.
Transactions by insiders
Recent insider trading involved Vazquez Chris, Chief Accounting Officer, that happened on Nov 10 ’25 when 13.0 shares were sold. Chief Development Officer, Pestano Gary Anthony completed a deal on Nov 10 ’25 to sell 23.0 shares. Meanwhile, Chief Commercial Officer O’Kane Kieran sold 25.0 shares on Nov 10 ’25.
